Transcan-3: Sustained collaboration of national and regional programmes in cancer research. Project funded from EU's Horizon 2020 programme, GA No 964264

Joined May 2021
22 Photos and videos
๐Ÿ“ข The TRANSCAN-4 Joint Transnational Call #JTC2026 is officially open today! ๐Ÿ”ฌ Topic: โ€œTranslational Research on Cancer Metabolism: Multidisciplinary Approaches for Diagnosis and Treatmentโ€ ๐Ÿ—“๏ธ Pre-proposals due: 21 July 2026 More info ๐Ÿ‘‡ bit.ly/4wGwYZU #TRANSCAN4
1
468
๐Ÿ‡ฎ๐Ÿ‡น Save the date: TRANSCAN-3 JTC 2023 symposium in Milan on Oct 28โ€“29. ๐Ÿ‘ฅ Projects, workshops, training & more โ€” especially for early career researchers.
46
๐Ÿ“ŒEPILUNAR is one of the 13 projects funded by the 2023 TRANSCAN-3 JTC and is aimed at discovering novel biomarkers to identify mNSCLC patients who will benefit from immune checkpoint inhibitors (ICIs). Click here to know more about the project ๐Ÿ‘‰ bit.ly/EPILUNAR
1
85
EPILUCAFS is one of the 13 projects funded by the 2023 TRANSCAN-3 JTC and is aimed at investigatin how chronic inflammation related to psychosocial stress shapes the tumour microenvironment and tumour draining lymph nodes in lung cancer. To know more ๐Ÿ‘‰ bit.ly/EPILUCAFS
70
EPI_T-ALL is one of the 13 projects funded by the 2023 TRANSCAN-3 JTC and is aimed at characterizing critical molecular events that drive the progression of human T-cell progenitors from normal to outright malignant states. To know more ๐Ÿ‘‰ bit.ly/EPI_T-ALL
78
DICE is one of the 13 projects funded by the 2023 TRANSCAN-3 JTC, and it aims to untangle the epigenomic impact of dietary intervention (namely anti- inflammatory diet, AID) for the identification of new epigenetic therapeutic targets. To know more ๐Ÿ‘‰ bit.ly/DICE_JTC
1
124
๐Ÿ“š Last 10 and 11 October, the SEC for the Transcan-3 JTC 2024 gathered in Catania for the pre-proposal evaluation of JTC 2024 of TRANSCAN-3. ๐Ÿ’ก Today, the Funders will decide, based on the ranking list, how many proposals will advance to the second stage.
123
DC2M-TAEC is one of the 13 projects funded by the 2023 TRANSCAN-3 JTC, and it aims to develop a platform to simultaneously generate methylation and sequencing results. Click here to know more ๐Ÿ‘‰ bit.ly/DC2M-TAEC
110
Today is World Cancer Research Day, an event that aims to promote global collaboration for cancer research and to increase survival, facilitate access to scientific advances worldwide, and reduce the global burden of cancer. Learn about our commitment ๐Ÿ‘‰ transcan.eu/
1
1
5
161
The first Meeting of the SEC for the Transcan-3 JTC 2024 is approaching! On October 10th - 11th, 2024, we will celebrate our second Symposium in Catania, Italy, featuring the projects of our call JTC 2022 and the evaluation of pre-proposals of our latest call JTC 2024.
2
2
164
๐Ÿ“ข The Transcan-3 JTC 2023 has successfully concluded, selecting 13 consortia for funding, with an allocation of almost 17 million euros dedicated to advancing translational research on cancer epigenetics. Discover the awarded projects on our website ๐Ÿ‘‰ lnkd.in/d4BydUtw
2
90
โž๐—ก๐—ฒ๐˜„ ๐—™๐—ฟ๐—ผ๐—ป๐˜๐—ถ๐—ฒ๐—ฟ๐˜€ ๐—ถ๐—ป ๐—–๐—ฎ๐—ป๐—ฐ๐—ฒ๐—ฟ ๐—œ๐—บ๐—บ๐˜‚๐—ป๐—ผ๐˜๐—ต๐—ฒ๐—ฟ๐—ฎ๐—ฝ๐˜†โž, organized by ISI and SITC, is set to take place on ๐—ฆ๐—ฒ๐—ฝ๐˜๐—ฒ๐—บ๐—ฏ๐—ฒ๐—ฟ ๐Ÿญ๐˜€๐˜, prior to the 7th European Congress of Immunology (ECI) in Dublin, Ireland. To register: sitcancer.org/isi

181
๐Ÿ“ฃ ๐—ง๐—–๐Ÿฏ ๐—ฎ๐—ป๐—ป๐—ผ๐˜‚๐—ป๐—ฐ๐—ฒ๐˜€ ๐˜๐—ต๐—ฎ๐˜ ๐˜๐—ต๐—ฒ ๐Ÿฏ๐—ฟ๐—ฑ ๐—๐—ผ๐—ถ๐—ป๐˜ ๐—ง๐—ฟ๐—ฎ๐—ป๐˜€๐—ป๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐—–๐—ฎ๐—น๐—น ๐—ณ๐—ผ๐—ฟ ๐—ฃ๐—ฟ๐—ผ๐—ฝ๐—ผ๐˜€๐—ฎ๐—น๐˜€ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฐ (๐—๐—ง๐—– ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฐ) ๐˜„๐—ถ๐—น๐—น ๐—ฏ๐—ฒ ๐—น๐—ฎ๐˜‚๐—ป๐—ฐ๐—ต๐—ฒ๐—ฑ ๐—ถ๐—ป ๐—”๐—ฝ๐—ฟ๐—ถ๐—น ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฐโ— Visit the website for all details: bit.ly/49mCOTn

3
2
310
Don't forget to subscribe toย Transcan-3ย newsletter here:ย bit.ly/3sunwN7 It is the best way to stay updated on news, events and funding opportunities, such as the upcoming JTC2024. Stay tuned! #cancer #oncology #research
2
2
453
We would like to start the new year sharing with you all the successful story of a project funded by TRANSCAN-2. The project INTRACOLOR has discovered new potentially targetable alterations for a molecular subpopulation of methastatic CRC (mCRC) patients. bit.ly/47uLQgb

1
187
๐ŸŽ„ We are getting close to Christmas and we would like to wish you all happy and relaxing days and a pleasant end of this year... But, most important: a great start of 2024! ๐ŸŽ‰ The next year we will come back with fresh news on the ๐˜‚๐—ฝ๐—ฐ๐—ผ๐—บ๐—ถ๐—ป๐—ด ๐—๐—ง๐—–๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฐ, so stay tuned!
220
The 6th edition of our newsletter is officially out: enjoy reading! transcan.eu/kdocs/2116495/trโ€ฆ

96
Do you want to stay updated on Transcan-3 activities, news and funding opportunities? Subscribe to our newsletter here: bit.ly/3sunwN7 The next newsletter will be published in December, so stay tuned! #cancer #oncology #research

1
3
141
๐—ฆ๐—œ๐— ๐— ๐—•๐—”๐—ฃ project will study the interactions between local mechanisms of tumorigenesis and the hostโ€™s systemic immunity to uncover mechanisms, non-invasive biomarkers and actionable targets to improve early detection and treatment of PDAC bit.ly/40qkPIC

1
83
๐Ÿง  #Glioblastoma (GBM) is the most frequent and aggressive brain #tumour, whose treatment has not changed in the last 25 years. ๐—ฅ๐—ฒ๐—ฎ๐—ฐ๐—ต๐—š๐—Ÿ๐—œ๐—ข project, funded by JTC 2022, works on approaches with drug loaded and tumour-targeted nanoparticles transcan.eu/output-results/fโ€ฆ

141